Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02483949
Other study ID # HEALD-GDM
Secondary ID
Status Completed
Phase N/A
First received May 28, 2015
Last updated January 12, 2018
Start date June 2015
Est. completion date July 2017

Study information

Verified date July 2016
Source Athabasca University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To examine the effectiveness of a group-based lifestyle modification program followed by peer-led telephone counselling for type 2 diabetes (T2D) and cardiovascular disease risk reduction. The lifestyle modification program will support daily ambulatory activity and low glycemic index food intake among women with previous gestational diabetes mellitus (GDM).


Description:

Study Objective:

To examine the effectiveness of a group-based lifestyle modification program followed by peer-led telephone counselling for type 2 diabetes (T2D) and cardiovascular disease risk reduction. The lifestyle modification program will support daily ambulatory activity and low glycemic index food intake among women with previous GDM.

Methods:

To achieve the study objective, the HEALD-GDM lifestyle modification program already proven effective for adults with T2D among women with previous GDM within 12 months postpartum will be evaluated. Women will take part in either the HEALD-GDM program (intervention) or in usual care (control). To evaluate the effectiveness of HEALD-GDM, a randomized, two-arm, before and after study design is proposed. Potentially eligible participants will be recruited from Diabetes in Pregnancy Clinics in Calgary and Edmonton, Alberta. Following identification of eligible participants, the investigators will randomize 100 participants to either the HEALD-GDM program or to usual care control (i.e., 50 per group). A Canadian Society of Exercise Physiology certified instructor (Exercise Specialist) trained in HEALD-GDM delivery will lead the program. Group-based classes will be held at community recreational centres in Calgary and Edmonton (one site each) in months one and four of the 24-week HEALD-GDM program. Theory-guided peer-led telephone counselling will supplement the program. HEALD-GDM focuses broadly on T2D prevention through lifestyle modification and will be based on a proven effective pedometer-based active living behaviour.

The primary outcome will be change in objectively measured moderate and vigorous physical activity at assessment appointments (baseline and 24 weeks). Secondary outcomes include: 1) body mass, 2) glycemic control (hemoglobin A1c), 3) musculoskeletal and cardiorespiratory fitness, 4) dietary intake, 5) metabolic biomarkers, 6) health-related quality of life (HRQL), social-cognitive mediators and 7) mental health.

Significance:

Evidence for appropriate lifestyle modification programs for this high-risk population is lacking. This study will serve to inform best practices for diabetes and cardiovascular disease risk reduction through known modifiable risk reduction targets such as healthy eating and active living.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date July 2017
Est. primary completion date July 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- laboratory confirmed previous and recent (within last 12 months) gestational diabetes mellitus • informed consent

Exclusion Criteria:

- unable to provide informed consent or unwilling to participate in the study

- unable to read, understand and converse in English

- contraindications based on the Canadian Society for Exercise Physiology Physical Activity Readiness Questionnaire Plus (PAR-Q+)

- currently enrolled in other diabetes-related research studies

- pregnant or planning another pregnancy in the next 12 months (any participants becoming pregnant at any point during the study will only contribute data prior to their pregnancy date)

- hemoglobin A1c >6.5% or clinical suspicion of type 1 or type 2 diabetes

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Healthy Eating and Active Living for Diabetes - Gestational Diabetes Mellitus


Locations

Country Name City State
Canada Athabasca University Athabasca Alberta
Canada Alliance for Canadian Health Outcomes Research in Diabetes Edmonton Alberta

Sponsors (1)

Lead Sponsor Collaborator
Athabasca University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline to 6 months of moderate and vigorous physical activity (walking). Accelerometer derived MVPA 6 months
Secondary Change from baseline to 6 months in Low Glycemic Index foods. Low glycemic index food intake will be assessed using three-day food records. 6 months

External Links